High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase

Blood

Volumn 91, Issue 7, 1998, Pages 2406-2414

  Wang, J C Y ^b   Lapidot, T ^b   Cashman, J D ^b   Doedens, M ^b   Addy, L ^b   Sutherland, D R ^b   Nayar, R ^b   Laraya, P ^b   Minden, M ^b   Keating, A ^b   Eaves, A C ^b   Eaves, C J ^b   Dick, J E ^a  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FEMALE; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; SCID MOUSE;

EID: 0032055156     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.7.2406.2406_2406_2414     Document Type: Article

References (39)

1. Nowell P, Hungerford D: A minute chromosome in human chronic granulocytic leukemia. Science 132:1497, 1960
2. Rowley JD: A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290, 1973
3. Heisterkamp N, Stephenson JR, Groffen J, Hansen PF, de Klein A, Bartram CR, Grosveld G: Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature 306:239, 1983
4. Gishizky ML, Johnson-White J, Wine ON: Evaluating the effect of P210 BCR/ABL on growth of hematopoietic progenitor cells and its role in the pathogenesis of human chronic myelogenous leukemia. Semin Hematol 30:6, 1993
5. Jackson P, Baltimore D, Picard D: Hormone-conditional transformation by fusion proteins of c-Abl and its transforming variants. EMBO J 12:2809, 1993
6. Kantarjian HM, Deisseroth A, Kurzrock R, Estrov Z, Talpaz M: Chronic myelogenous leukemia: A concise update. Blood 82:691, 1993
7. Eaves CJ, Eaves AC: Cell culture studies in CML. Baillieres Clin Haematol 1:931, 1987
8. Eaves C, Cashman J, Zoumbo N, Bamett M, Eaves A: Biological strategies for the selective manipulation of normal and leukemic stem cells. Stem Cells 11:109, 1993
9. 1 + chronic myelogenous leukemia and effects of intensive treatment. Blood 59:793, 1982
10. Kantarjian HM, Vellekoop L, McCredie KB, Keating MJ, Hester J, Smith T, Barlogie B, Trujillo J, Freireich EJ: Intensive combination chemotherapy (ROAP 10) and splenectomy in the management of chronic myelogenous leukemia. J Clin Oncol 3:192, 1985
11. Talpaz M, Kantarjian H, Kurzrock R, Trujillo JM, Gutterman JU: Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Ann Intern Med 114:532, 1991
12. Coulombel L, Kalousek DK, Eaves CJ, Gupta CM, Eaves AC: Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. N Engl J Med 308:1493, 1983
13. Udomsakdi C, Eaves CJ, Swolin B, Reid DS, Barnett MJ, Eaves AC: Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level. Proc Natl Acad Sci USA 89:6192, 1992
14. Petzer AL, Eaves CJ, Barnett MJ, Eaves AC: Selective expansion of primitive normal hematopoietic cells in cytokine-supplemented cultures of purified cells from patients with chronic myeloid leukemia. Blood 90:64, 1997
15. Sawyers CL, Gishizky ML, Quan S, Golde DW, Witte ON: Propagation of human blastic leukemias in the SCID mouse. Blood 79:2089, 1992
16. Cesano A, Hoxie JA, Lange B, Nowell PC, Bishop J, Santoli D: The severe combined immunodeficient (SCID) mouse as a model for myeloid leukemias. Oncogene 7:827, 1992
17. Namikawa R, Ueda R, Kyoizumi S: Growth of human myeloid leukemia in the human marrow environment of SCID-hu mice. Blood 82:2526, 1993
18. Sirard C, Lapidot T, Vormoor J, Cashman JD, Doedens M, Murdoch B, Jamal N, Messner H, Addy L, Minden M, Laraya P, Keating A, Eaves A, Lansdorp PM, Eaves CJ, Dick JE: Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. Blood 87:1539, 1996
19. Lapidot T, Pflumio F, Doedens M, Murdoch B, Williams DE, Dick J: Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 255:1137, 1992
20. Vormoor J, Lapidot T, Pflumio F, Risdon G, Patterson B, Broxmeyer HE, Dick JE: Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. Blood 83:2489, 1994
21. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, McKenna S, Mobraaten L, Rajan TV, Greiner DL, Leiter EH: Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 154:180, 1995
22. Larochelle A, Vormoor J, Lapidot T, Sher G, Furukawa T, Li Q Shultz LD, Olivieri NF, Stamatoyannopoulos G, Dick JE: Engraftment of immune-deficient mice with primitive hematopoietic cells from b-thalassemia and sickle cell anemia patients: Implications for evaluating human gene therapy protocols. Hum Mol Genet 4:163, 1995
23. Cashman JD, Lapidot T, Wang JCY, Doedens M, Shultz LD, Lansdorp P, Dick JE, Eaves CJ: Kinetic evidence of the regeneration of multi-lineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood 89:4307, 1997
24. Larochelle A, Vormoor J, Hanenberg H, Wang JCY, Bhatia M, Lapidot T, Moritz T, Murdoch B, Xiao XL, Kato I, Williams DA, Dick JE: Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nat Med 2:1329, 1996
25. Bonnet D, Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3:730, 1997
26. Sutherland DR, Marsh JCW, Davidson J, Baker MA, Keating A, Mellors A: Differential sensitivity of CD34 epitopes to cleavage by Pasteurella haemolytica glycoprotease: Implications for purification of CD34-positive progenitor cells. Exp Hematol 20:590, 1992
27. Marsh JCW, Sutherland DR, Davidson J, Mellors A, Keating A: Retention of progenitor cell function in CD34+ cells purified using a novel O-sialoglycoprotease. Leukemia 6:926, 1992
28. Sutherland DR, Yeo EL, Stewart AK, Nayar R, DiGuisto R, Zanjani E, Huffman R, Murray LJ: identification of CD34+ subsets following glycoprotease selection: Engraftment of CD34+/Thy-1+/Lin-stem cells in fetal sheep. Exp Hematol 24:795, 1996
29. Sutherland DR, Keating A, Nayar R, Anania S, Stewart AK: Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp Hematol 22:1003, 1994
30. Dick JE, Kamel-Reid S, Murdoch B, Doedens M: Gene transfer into normal human hematopoietic cells using in vitro and in vivo assays. Blood 78:624, 1991
31. Heisterkamp N, Stam K, Groffen J, de Klein A. Grosveld G: Structural organization of the her gene and its role in the Ph′ translocation. Nature 315:758, 1985
32. Hogge DE, Lansdorp PM, Reid D, Gerhard B, Eaves CJ: Enhanced detection, maintenance, and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human steel factor, interleukin-3. and granulocyte colony-stimulating factor. Blood 88:3765, 1996
33. Petzer AL, Eaves CJ, Lansdorp PM, Ponchio L, Barnett MJ, Eaves AC: Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia. Blood 88:2162, 1996
34. Hauch M, Gazzola MV, Small T, Bordignon C, Bamett L, Cunningham I, Castro-Malaspirua H, O'Reilly RJ, Keever CA: Antileukemia potential of mterleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia. Blood 75:2250, 1990
35. Meseri A, Delwail V, Brizard A, Lecron JC, Pelletier D, Guilhot F, Tanzer J, Goube de Laforest P: Endogenous lymphokine activated killer cell activity and cytogenetic response in chronic myelogenous leukaemia treated with a-interferon. Br J Haematol 83:218, 1993
36. Udomsakdi C, Eaves CJ, Lansdorp P, Eaves AC: Phenotypic heterogeneity of primitive leukemic hematopoietic cells in patients with chronic myeloid leukemia. Blood 80:2522, 1992
37. 1o population in chronic myeloid leukemia: An analysis using interphase fluorescence in situ hybridization. Blood 86:737, 1995
38. Verfaillie CM, Miller WJ, Boylan K, McGlave PB: Selection of benign primitive haematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. Blood 79:1003, 1992
39. Waye S, Willard H: Structure, organization and sequence of alpha satellite DNA from human chromosome 17: Evidence for evolution by unequal crossing-over and an ancestral pentamer repeat shared with the human X chromosome. Mol Cell Biol 6:3156, 1986